Form 4 Filing for Edwards Lifesciences Corp - Officer Transactions

Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), reported a series of transactions on April 6, 2026. Lippis acquired 1019 shares of Common Stock at a price of $59.26 per share, increasing his post-transaction holdings to 34952.9103 shares. This acquisition was part of a Rule 10b5-1 trading plan. Concurrently, Lippis disposed of 1019 shares of Common Stock at a weighted average price of $80.98, with individual transactions ranging from $80.64 to $81.07. This resulted in a post-transaction share count of 33933.9103. Additionally, Lippis exercised an employee stock option for 1019 shares of Common Stock at a price of $0.00, with an exercise price of $59.2567 for the underlying shares. This increased his post-transaction option holdings to 2038 shares. All transactions were executed under a Rule 10b5-1 trading plan.